Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38

The aim of this study is to contribute to a better description of the genotypic and phenotypic spectrum of DFNA6/14/38 and aid in counseling future patients identified with this variant. Therefore, we describe the genotype and phenotype in a large Dutch–German family (W21-1472) with autosomal dominant non-syndromic, low-frequency sensorineural hearing loss (LFSNHL). Exome sequencing and targeted analysis of a hearing impairment gene panel were used to genetically screen the proband. Co-segregation of the identified variant with hearing loss was assessed by Sanger sequencing. The phenotypic evaluation consisted of anamnesis, clinical questionnaires, physical examination and examination of audiovestibular function. A novel likely pathogenic WFS1 variant (NM_006005.3:c.2512C>T p.(Pro838Ser)) was identified in the proband and found to co-segregate with LFSNHL, characteristic of DFNA6/14/38, in this family. The self-reported age of onset of hearing loss (HL) ranged from congenital to 50 years of age. In the young subjects, HL was demonstrated in early childhood. At all ages, an LFSNHL (0.25–2 kHz) of about 50–60 decibel hearing level (dB HL) was observed. HL in the higher frequencies showed inter-individual variability. The dizziness handicap inventory (DHI) was completed by eight affected subjects and indicated a moderate handicap in two of them (aged 77 and 70). Vestibular examinations (n = 4) showed abnormalities, particularly in otolith function. In conclusion, we identified a novel WFS1 variant that co-segregates with DFNA6/14/38 in this family. We found indications of mild vestibular dysfunction, although it is uncertain whether this is related to the identified WFS1 variant or is an incidental finding. We would like to emphasize that conventional neonatal hearing screening programs are not sensitive to HL in DFNA6/14/38 patients, because high-frequency hearing thresholds are initially preserved. Therefore, we suggest screening newborns in DFNA6/14/38 families with more frequency-specific methods.

[1]  Zhiming Lu,et al.  A Novel Missense WFS1 Variant: Expanding the Mutational Spectrum Associated with Nonsyndromic Low-Frequency Sensorineural Hearing Loss , 2022, BioMed research international.

[2]  Marina T. DiStefano,et al.  Clinical evaluation and etiologic diagnosis of hearing loss: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). , 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

[3]  M. Bitner-Glindzicz,et al.  WFS1-Associated Optic Neuropathy: Genotype-Phenotype Correlations and Disease Progression. , 2022, American journal of ophthalmology.

[4]  T. Casavant,et al.  AudioGene: refining the natural history of KCNQ4, GSDME, WFS1, and COCH-associated hearing loss , 2022, Human Genetics.

[5]  T. Casavant,et al.  AudioGene: refining the natural history of KCNQ4, GSDME, WFS1, and COCH-associated hearing loss , 2022, Human genetics.

[6]  James E. Allen,et al.  Ensembl 2022 , 2021, Nucleic Acids Res..

[7]  Tao Xu,et al.  WFS1 functions in ER export of vesicular cargo proteins in pancreatic β-cells , 2021, Nature Communications.

[8]  C. Polychronakos,et al.  Prevalence and phenotypic features of diabetes due to recessive, non-syndromic WFS1 mutations. , 2021, European journal of endocrinology.

[9]  P. Yu-Wai-Man,et al.  A mutant wfs1 zebrafish model of Wolfram syndrome manifesting visual dysfunction and developmental delay , 2021, Scientific Reports.

[10]  M. Borowiec,et al.  Multiomic analysis on human cell model of wolfram syndrome reveals changes in mitochondrial morphology and function , 2021, Cell Communication and Signaling.

[11]  J. Shendure,et al.  CADD-Splice—improving genome-wide variant effect prediction using deep learning-derived splice scores , 2021, Genome Medicine.

[12]  Peter B. McGarvey,et al.  UniProt: the universal protein knowledgebase in 2021 , 2020, Nucleic Acids Res..

[13]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[14]  F. Urano,et al.  Calpain inhibitor and ibudilast rescue β cell functions in a cellular model of Wolfram syndrome , 2020, Proceedings of the National Academy of Sciences.

[15]  T. Casavant,et al.  A comparative analysis of genetic hearing loss phenotypes in European/American and Japanese populations , 2020, Human Genetics.

[16]  C. Cremers,et al.  A RIPOR2 in-frame deletion is a frequent and highly penetrant cause of adult-onset hearing loss , 2019, Journal of Medical Genetics.

[17]  L. Zagato,et al.  Endolymphatic hydrops and ionic transporters: genetic and biohumoral aspects , 2019, Journal of Neurology.

[18]  David G. Knowles,et al.  Predicting Splicing from Primary Sequence with Deep Learning , 2019, Cell.

[19]  S. T. Goverts,et al.  Speech Recognition Abilities in Normal-Hearing Children 4 to 12 Years of Age in Stationary and Interrupted Noise , 2018, Ear and hearing.

[20]  B. Delprat,et al.  ER-mitochondria cross-talk is regulated by the Ca2+ sensor NCS1 and is impaired in Wolfram syndrome , 2018, Science Signaling.

[21]  Alex Chapin,et al.  Expert Specification of the ACMG/AMP Variant Interpretation Guidelines for Genetic Hearing Loss , 2018, bioRxiv.

[22]  Y. Naito,et al.  WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis , 2018, PloS one.

[23]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[24]  K. Majamaa,et al.  A nonsynonymous mutation in the WFS1 gene in a Finnish family with age-related hearing impairment , 2017, Hearing Research.

[25]  A. Hattersley,et al.  Dominant ER Stress–Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts , 2017, Diabetes.

[26]  R. Pfundt,et al.  Diagnostic exome sequencing in 266 Dutch patients with visual impairment , 2017, European Journal of Human Genetics.

[27]  R. Pfundt,et al.  The diagnostic yield of whole-exome sequencing targeting a gene panel for hearing impairment in The Netherlands , 2016, European Journal of Human Genetics.

[28]  Trevor Hastie,et al.  REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. , 2016, American journal of human genetics.

[29]  V. Choubey,et al.  Role of Mitochondrial Dynamics in Neuronal Development: Mechanism for Wolfram Syndrome , 2016, PLoS biology.

[30]  G. Jacobson,et al.  The development of the vanderbilt pediatric dizziness handicap inventory for patient caregivers (DHI-PC). , 2015, International journal of pediatric otorhinolaryngology.

[31]  A. Beynon,et al.  Vestibular function and temporal bone imaging in DFNB1 , 2015, Hearing Research.

[32]  M. Strupp,et al.  Diagnostic criteria for Menière's disease. , 2015, Journal of vestibular research : equilibrium & orientation.

[33]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[34]  G. Rutter,et al.  Sarco(endo)plasmic reticulum ATPase is a molecular partner of Wolfram syndrome 1 protein, which negatively regulates its expression. , 2015, Human molecular genetics.

[35]  X. Liu,et al.  Whole-Exome Sequencing to Decipher the Genetic Heterogeneity of Hearing Loss in a Chinese Family with Deaf by Deaf Mating , 2014, PloS one.

[36]  O. Días,et al.  WFS1 and non-syndromic low-frequency sensorineural hearing loss: a novel mutation in a Portuguese case. , 2014, Gene.

[37]  Rachel L. Goldfeder,et al.  Autosomal Dominant Diabetes Arising From a Wolfram Syndrome 1 Mutation , 2013, Diabetes.

[38]  S. Bhattacharya,et al.  Wolfram gene (WFS1) mutation causes autosomal dominant congenital nuclear cataract in humans , 2013, European Journal of Human Genetics.

[39]  A. Devereau,et al.  Practice Guidelines for the Evaluation of Pathogenicity and the Reporting of Sequence Variants in Clinical Molecular Genetics . , 2013 .

[40]  Jeroen F. J. Laros,et al.  LOVD v.2.0: the next generation in gene variant databases , 2011, Human mutation.

[41]  P. Dai,et al.  Identification of two novel missense WFS1 mutations, H696Y and R703H, in patients with non-syndromic low-frequency sensorineural hearing loss. , 2011, Journal of genetics and genomics = Yi chuan xue bao.

[42]  M. Permutt,et al.  Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. , 2010, The Journal of clinical investigation.

[43]  R. Pennings,et al.  Hearing Impairment in Genotyped Wolfram Syndrome Patients , 2008, The Annals of otology, rhinology, and laryngology.

[44]  C. Cremers,et al.  Missense mutations in POU4F3 cause autosomal dominant hearing impairment DFNA15 and affect subcellular localization and DNA binding , 2008, Human mutation.

[45]  Naomi F. Bramhall,et al.  A novel WFS1 mutation in a family with dominant low frequency sensorineural hearing loss with normal VEMP and EcochG findings , 2008, BMC Medical Genetics.

[46]  A. Middleton.  Attitudes of deaf people and their families towards issues surrounding genetics , 2007 .

[47]  H. Katagiri,et al.  WFS1 protein modulates the free Ca2+ concentration in the endoplasmic reticulum , 2006, FEBS letters.

[48]  H. Aburatani,et al.  WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells. , 2006, Human molecular genetics.

[49]  T. Hansen,et al.  Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene , 2005, Journal of Medical Genetics.

[50]  Kathryn L. Lipson,et al.  WFS1 Is a Novel Component of the Unfolded Protein Response and Maintains Homeostasis of the Endoplasmic Reticulum in Pancreatic β-Cells* , 2005, Journal of Biological Chemistry.

[51]  I. Fokkema,et al.  LOVD: Easy creation of a locus‐specific sequence variation database using an “LSDB‐in‐a‐box” approach , 2005, Human mutation.

[52]  H. Katagiri,et al.  Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. , 2004, Human molecular genetics.

[53]  J. Furman,et al.  Is Perception of Handicap Related to Functional Performance in Persons with Vestibular Dysfunction? , 2004, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[54]  M. Permutt,et al.  Wolframin Expression Induces Novel Ion Channel Activity in Endoplasmic Reticulum Membranes and Increases Intracellular Calcium* , 2003, Journal of Biological Chemistry.

[55]  C. Cremers,et al.  Sex-Related Hearing Impairment in Wolfram Syndrome Patients Identified by Inactivating WFS1 Mutations , 2003, Audiology and Neurotology.

[56]  C. Cremers,et al.  Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease , 2003, Human mutation.

[57]  K. Gerbitz,et al.  Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. , 2003, Human molecular genetics.

[58]  James W. Hall,et al.  Mutations in the Wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss. , 2003, Archives of otolaryngology--head & neck surgery.

[59]  Patrick L M Huygen,et al.  Progression of low-frequency sensorineural hearing loss (DFNA6/14-WFS1). , 2003, Archives of otolaryngology--head & neck surgery.

[60]  Y. Oka,et al.  The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells , 2003, Histochemistry and Cell Biology.

[61]  A. Parving,et al.  Recommendations for the Description of Genetic and Audiological Data for Families with Nonsyndromic Hereditary Hearing Impairment , 2003 .

[62]  C. Cremers,et al.  Characterizing and Distinguishing Progressive Phenotypes in Nonsyndromic Autosomal Dominant Hearing Impairment , 2003 .

[63]  C. Cremers,et al.  Autosomal Dominant Low-Frequency Hearing Impairment (DFNA6/14): A Clinical and Genetic Family Study , 2002, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[64]  C. Cremers,et al.  Mutations in the WFS1 gene that cause low-frequency sensorineural hearing loss are small non-inactivating mutations , 2002, Human Genetics.

[65]  S. Leal,et al.  Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. , 2001, Human molecular genetics.

[66]  M. King,et al.  Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1. , 2001, Human molecular genetics.

[67]  Yoshifumi Watanabe,et al.  WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. , 2001, Human molecular genetics.

[68]  Yoshifumi Watanabe,et al.  WFS 1 ( Wolfram syndrome 1 ) gene product : predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain , 2001 .

[69]  C. Cremers,et al.  A gene for autosomal dominant hearing impairment (DFNA14) maps to a region on chromosome 4p16.3 that does not overlap the DFNA6 locus , 1999, Journal of medical genetics.

[70]  T. Meitinger,et al.  Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. , 1998, Human molecular genetics.

[71]  P. Behn,et al.  A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) , 1998, Nature Genetics.

[72]  G. Camp,et al.  The hereditary hearing loss homepage , 1997 .

[73]  T. Barrett,et al.  Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome , 1995, The Lancet.

[74]  F. Bess,et al.  A gene for autosomal dominant nonsyndromic hereditary hearing impairment maps to 4p16.3. , 1995, Human molecular genetics.

[75]  G F Smoorenburg,et al.  Intelligibility of Dutch CVC syllables and sentences for listeners with normal hearing and with three types of hearing impairment. , 1995, Audiology : official organ of the International Society of Audiology.

[76]  N. E. MORTON,et al.  Genetic Epidemiology of Hearing Impairment , 1991, Annals of the New York Academy of Sciences.

[77]  C. Newman,et al.  The development of the Dizziness Handicap Inventory. , 1990, Archives of otolaryngology--head & neck surgery.